Position in ALT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,336,948
+$9,784,069 QoQ
Shares Held
3,400,312
+2280.1% QoQ
Ownership
1.75%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 210 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ALT ranks #93 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ALT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,336,948 | 3,400,312 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $552,879 | 142,863 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $2,181,014 | 214,245 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $21,451,194 | 1,304,024 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,001,022 | 1,018,091 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,443,014 | 550,685 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,155,903 | 846,618 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,685,410 | 620,678 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,945,188 | 348,823 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||